Home›Legal›BPC-157 in New York
BPC-157 in New York: Legal Status & Provider Guide (2026)
Quick Answer
BPC-157 is a prescription substance in the United States. BPC-157 has no FDA-approved drug application. It is classified as a research peptide and cannot be compounded by 503A/503B pharmacies under current federal guidance. Clinical use in the U.S. occurs in a legal gray area — consult a healthcare attorney and licensed prescriber for current federal standing. In New York, compounding is governed by the New York State Board of Pharmacy (NYSBP). New York requires a collaborative practice agreement for nurse practitioners prescribing controlled substances, but NPs with full prescriptive authority may prescribe most compounded peptides independently. Physician assistants require physician supervision for prescribing. New York's telehealth prescribing rules require prescribers to hold a New York license; interstate telemedicine prescribing is tightly regulated.
Federal Legal Status
FDA Approval Status
Not FDA-approved as a drug. Not on any FDA bulk substances list for compounding.
Compounding Pharmacy Rules (Federal)
BPC-157 is not on the FDA 503A or 503B bulk substances lists, meaning licensed compounding pharmacies cannot legally compound it for individual patients under federal law. Its status as a bulk substance for compounding has been contested and remains legally uncertain. Some providers offer it under state-level regulatory frameworks, but federal compliance risk is elevated.
Also Known As
Body Protection Compound 157 · PL 14736
Primary Research Areas
- Tissue repair
- Gut health
- Tendon and ligament healing
- Angiogenesis
New York Pharmacy Board & Compounding Rules
Compounding Overview
New York has among the most stringent pharmacy and prescribing regulations in the country. The New York State Board of Pharmacy enforces USP 797 and 795 standards and requires all compounding pharmacies to meet detailed quality and documentation requirements. New York has been particularly active in enforcing against unapproved compounded medications. In-state telehealth peptide providers are subject to strict New York Medical Board oversight.
Notable Rules
- New York requires compounding pharmacies to register separately for sterile compounding.
- The New York Department of Health has enforcement authority over unlicensed pharmaceutical activity.
- New York has stricter-than-federal requirements for documentation of medical necessity for compounded preparations.
- Interstate prescribing into New York requires a New York state license.
- New York and Pennsylvania maintain reciprocal pharmacy licensure recognition for some categories.
Prescribing Requirements in New York
New York requires a collaborative practice agreement for nurse practitioners prescribing controlled substances, but NPs with full prescriptive authority may prescribe most compounded peptides independently. Physician assistants require physician supervision for prescribing. New York's telehealth prescribing rules require prescribers to hold a New York license; interstate telemedicine prescribing is tightly regulated.
About BPC-157
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It has been studied in animal models for tissue repair, gut protection, and angiogenesis. No completed Phase III human trials exist as of 2026.
For more research information, mechanism of action, and provider availability, see the BPC-157 research profile on PeptideBase.
Frequently Asked Questions
- Is BPC-157 legal in the United States?
- BPC-157 exists in a legal gray area. It is not FDA-approved and is not on the 503A/503B bulk compounding lists. Research-use possession is generally not a federal crime, but commercial sale and compounding for human use carry significant legal risk.
- Can a doctor prescribe BPC-157?
- A licensed prescriber may write an order for BPC-157, but compounding pharmacies subject to FDA oversight cannot legally compound it. Some providers operate under state regulations or as research programs. Patients should consult both a physician and legal counsel.
BPC-157 Providers in New York
No providers currently listed in New York for BPC-157. Browse the full directory to find providers offering BPC-157.
Browse all BPC-157 providers →BPC-157 Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare BPC-157 legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .